The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue
Background For enhancement of drug effectiveness and reduction of drug toxicity, liposomal drugs have been studied in laboratories and clinics for decades. Although the results obtained from in vitro are encouraging, but the results from in vivo tests were not satisfactory. The main reasons for this...
Saved in:
Main Authors: | Xing Qing Pan (Author), Susie Jones (Author), Karen Cox (Author) |
---|---|
Format: | Book |
Published: |
AboutScience Srl,
2006-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue
by: Xing Qing Pan, et al.
Published: (2006) -
Pegylated liposomal doxorubicin in ovarian cancer
by: Robert Strother, et al.
Published: (2009) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
by: Gabriella Ferrandina, et al.
Published: (2010) -
Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia
by: Joana Moreira-Barros, et al.
Published: (2018) -
Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
by: S. Yost, et al.
Published: (2019)